Ovarian Cancer Flashcards
T/F: Ovarian cancer is the leading cause of death in women.
True
T/F: Ovarian cancer is mostly curable.
False. Most arenotcured but patients are living longerwithcancer.
T/F: Staging ofOvarian canceris determined by clinical evaluation.
False. Surgically staged
Primary method of spread of ovarian cancer
shedding of tumor in intraperitoneal cavity
Rarely lymphatic/blood
Most common type of ovarian cancer
Epithelial ovarian cancer
60% of all ovarian neoplasms
80% of malignant ovarian tumors
Types of ovarian cancer (3)
Age of onset of each type
Epithelial: 60 y/o
Germ cell: 20-30 y/o
Sex cord stormal: younger women
T/F: Epithelial ovarian cancers have a better prognosis than germ cell tumors.
False. Germ cell tumors have better prognosis
Most common type of sex cord stormal tumors
Symptoms?
Granulosa cell tumor Symptoms: Precocious puberty Adenomatous hyperplasia (mass) Vaginal bleeding (postmenopausal women)
2 biggest risk factors of ovarian cancer
FHx andAge
Also:
- Nulliparty (having no kids)
- Endometriosis
- Early menarche, late menopause
- Late childbirth (age >35)
- Environmental factors
Delay of diagnosis of ovarian cancer isd/t ___
non-specific/vague symptoms
- Increased abdominal girth (ascites)
- Bloating
- Fatigue
- Abdominal pain, back pain, pain w/ sex
- Early satiety
- Indigestion
- Constipation
- Unexplained weight loss
- Urinary frequency or incontinence
T/F: HNPCC gene causes an increased risk in ovarian and breastcancer.
False. No increased risk in breast cancer. Increased risk in ovarian cancer.
T/F: PAP smear as a moderately effective screening tool for ovarian cancer.
False.PAP smear does NOT screen for ovarian cancer
There is NO truely effective method
T/F: AFP is a biomarker blood test used to screen for ovarian cancer.
False. CA125 is used as a non-specific blood test.
Not really that great but not that many options for screening for ovarian cancer
T/F:Simultaneous screening w/ CA125 + TVUS reducesovarian cancer mortality
False. It did NOT reduce
Which of the following is NOT a finding that suggestssuspicious pelvic mass inpostmenopausalwomen? A. Ascites B. Nodular/fixed pelvic mass C. Evidence of distant metastasis D. Elevated CA125 > 200 E. FHx of breast/ovarian cancer
D. Elevated CA125 > 35 inpostmenopausalwomen
Elevated CA125 > 200inpremenopausalwomen